A new study published in the journal Politics and the Life Sciences sheds light on the psychological roots of conspiracy ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

The newly established CAB has been formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The CAB ...

Gen Z is experiencing unprecedented levels of anxiety driven by digital and environmental stressors. This rise highlights the ...

Patrick Clancy claims his wife's doctors "knew or should have known that she presented a real, clear, and present danger of ...

This guidance is for integrated care boards (ICBs) and providers of eating disorder services and sets out how to design collaborative, integrated services that support all children, young people, and ...

RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...

After a clampdown on a popular psychoactive drug, doctors say many young people have switched to abusing a cheaper, addictive alternative.

[Disclaimer: This article is intended for US audiences] The mental health landscape has undergone a fundamental ...

An estimated 15.5 million American adults had an ADHD diagnosis in 2023 and half of them were diagnosed in adulthood, ...

News and commentary from the psychiatry world ...

Introduction High-risk pregnant women with physical or obstetric complications may develop depression and anxiety disorders that may worsen depending on the consequences of treatment and management ...